🚀 VC round data is live in beta, check it out!
Carl Zeiss Meditec Valuation Multiples
Discover revenue and EBITDA valuation multiples for Carl Zeiss Meditec and similar public comparables like MicroPort Scientific, LeMaitre Vascular, Andon Health, Rigaku and more.
Carl Zeiss Meditec Overview
About Carl Zeiss Meditec
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Founded
1977
HQ
Employees
4.8K
Website
Financials (LTM)
EV
$3B
Carl Zeiss Meditec Financials
Carl Zeiss Meditec reported last 12-month revenue of $3B and EBITDA of $417M.
In the same LTM period, Carl Zeiss Meditec generated $1B in gross profit, $417M in EBITDA, and $159M in net income.
Revenue (LTM)
Carl Zeiss Meditec P&L
In the most recent fiscal year, Carl Zeiss Meditec reported revenue of $3B and EBITDA of $424M.
Carl Zeiss Meditec expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 53% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $417M | XXX | $424M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $159M | XXX | $166M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Carl Zeiss Meditec Stock Performance
Carl Zeiss Meditec has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Carl Zeiss Meditec's stock price is $29.78.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | (0.6%) | XXX | XXX | XXX | $1.90 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCarl Zeiss Meditec Valuation Multiples
Carl Zeiss Meditec trades at 1.0x EV/Revenue multiple, and 6.6x EV/EBITDA.
EV / Revenue (LTM)
Carl Zeiss Meditec Financial Valuation Multiples
As of March 13, 2026, Carl Zeiss Meditec has market cap of $3B and EV of $3B.
Equity research analysts estimate Carl Zeiss Meditec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Carl Zeiss Meditec has a P/E ratio of 16.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 6.6x | XXX | 6.4x | XXX | XXX | XXX |
| EV/EBIT | 10.5x | XXX | 10.4x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| P/E | 16.4x | XXX | 15.7x | XXX | XXX | XXX |
| EV/FCF | 17.8x | XXX | 17.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Carl Zeiss Meditec Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Carl Zeiss Meditec Margins & Growth Rates
Carl Zeiss Meditec's revenue in the last 12 month grew by 2%.
Carl Zeiss Meditec's revenue per employee in the last FY averaged $0.5M.
Carl Zeiss Meditec's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Carl Zeiss Meditec's rule of X is 20% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Carl Zeiss Meditec Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | (4%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 22% | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 15% | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 42% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Carl Zeiss Meditec Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MicroPort Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| LeMaitre Vascular | XXX | XXX | XXX | XXX | XXX | XXX |
| Andon Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Rigaku | XXX | XXX | XXX | XXX | XXX | XXX |
| Elekta | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carl Zeiss Meditec M&A Activity
Carl Zeiss Meditec acquired XXX companies to date.
Last acquisition by Carl Zeiss Meditec was on XXXXXXXX, XXXXX. Carl Zeiss Meditec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Carl Zeiss Meditec
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCarl Zeiss Meditec Investment Activity
Carl Zeiss Meditec invested in XXX companies to date.
Carl Zeiss Meditec made its latest investment on XXXXXXXX, XXXXX. Carl Zeiss Meditec invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Carl Zeiss Meditec
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Carl Zeiss Meditec
| When was Carl Zeiss Meditec founded? | Carl Zeiss Meditec was founded in 1977. |
| Where is Carl Zeiss Meditec headquartered? | Carl Zeiss Meditec is headquartered in Germany. |
| How many employees does Carl Zeiss Meditec have? | As of today, Carl Zeiss Meditec has over 4K employees. |
| Is Carl Zeiss Meditec publicly listed? | Yes, Carl Zeiss Meditec is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Carl Zeiss Meditec? | Carl Zeiss Meditec trades under AFX ticker. |
| When did Carl Zeiss Meditec go public? | Carl Zeiss Meditec went public in 2000. |
| Who are competitors of Carl Zeiss Meditec? | Carl Zeiss Meditec main competitors are MicroPort Scientific, LeMaitre Vascular, Andon Health, Rigaku. |
| What is the current market cap of Carl Zeiss Meditec? | Carl Zeiss Meditec's current market cap is $3B. |
| What is the current revenue of Carl Zeiss Meditec? | Carl Zeiss Meditec's last 12 months revenue is $3B. |
| What is the current revenue growth of Carl Zeiss Meditec? | Carl Zeiss Meditec revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Carl Zeiss Meditec? | Current revenue multiple of Carl Zeiss Meditec is 1.0x. |
| Is Carl Zeiss Meditec profitable? | Yes, Carl Zeiss Meditec is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Carl Zeiss Meditec? | Carl Zeiss Meditec's last 12 months EBITDA is $417M. |
| What is Carl Zeiss Meditec's EBITDA margin? | Carl Zeiss Meditec's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Carl Zeiss Meditec? | Current EBITDA multiple of Carl Zeiss Meditec is 6.6x. |
| What is the current FCF of Carl Zeiss Meditec? | Carl Zeiss Meditec's last 12 months FCF is $154M. |
| What is Carl Zeiss Meditec's FCF margin? | Carl Zeiss Meditec's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Carl Zeiss Meditec? | Current FCF multiple of Carl Zeiss Meditec is 17.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.